Presentation

0 Comments

5 January 2017

Abbott Vascular – new technologies and global clinical programmes

Susan Veldhof, Director of Clinical Research, Abbot Vascular

Updates on bioresorbable scaffold trials, new drug-eluting stent technologies and mitral valve interventions

Previous | Next
Download

Summary

An overview of new developments in bioresorbable vascular scaffold trials (ABSORB), drug-eluting stent technologies and indications (e.g. side branch access), and transcatheter mitral valve interventions (MitraClip)

 

Download

Summary

An overview of new developments in bioresorbable vascular scaffold trials (ABSORB), drug-eluting stent technologies and indications (e.g. side branch access), and transcatheter mitral valve interventions (MitraClip)

 

You have to be a BCIS member to access this content

Either Sign in or register to become a member, today! Join BCIS Sign In